SENNA
- Product NDC
- 17856-8237
- Requested package NDC
- 17856-8237-2
- 11-digit product format
- 178568237
- Labeler code
- 17856
- Product ID
- 17856-8237_3b3f526b-e72b-4c6d-e063-6394a90a62e3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- SENNA
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- M
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-10-25
- Substance
- SENNOSIDES A AND B
- Active strength
- 417.12 mg/237mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 17856-8237 | 17856-8237-2 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 17856-8237 | 17856-8237-2 | I | Inactivated by FDA | excluded / ndc_excluded.zip | bd6a592717d7… | 303034d00443… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SENNA
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES A AND B | 417.12 mg/237mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1B5FPI42EN | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 702311 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8b7cc0d5-029b-43f7-a050-8771e7db4551 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-8237-1 | SENNA | 72 in 1 BOX, UNIT-DOSE | SYRUP | 72 | 4 | |
| 17856-8237-3 | SENNA | 120 in 1 BOX, UNIT-DOSE | SYRUP | 120 | 4 | |
| 17856-8237-4 | SENNA | 48 in 1 BOX, UNIT-DOSE | SYRUP | 48 | 4 | |
| 17856-8237-5 | SENNA | 72 in 1 BOX, UNIT-DOSE | SYRUP | 72 | 4 | |
| 17856-8237-5 | SENNA | 10 mL in 1 CUP, UNIT-DOSE | SYRUP | 10 | 4 | |
| 17856-8237-6 | SENNA | 5 mL in 1 CUP, UNIT-DOSE | SYRUP | 5 | 4 | |
| 17856-8237-7 | SENNA | 2.5 mL in 1 SYRINGE | SYRUP | 2.5 | 4 | |
| 17856-8237-8 | SENNA | 5 mL in 1 SYRINGE | SYRUP | 5 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-8237-1 | ML - Milliliter | 17856-8237 | d8613168-c348-481c-b159-d09baaedd940 | 1 | 2021-07-15 |
| 17856-8237-2 | ML - Milliliter | 17856-8237 | 259e62ac-56a0-4176-a183-98e107d6d0cf | 1 | 2022-05-04 |
| 17856-8237-3 | ML - Milliliter | 17856-8237 | 22b76930-4626-4cb0-b051-e659b6671544 | 1 | 2022-11-07 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-8237 | SENNA SYRUP [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, Legacy NDC, 8 package rows | 20240526_8b7cc0d5-029b-43f7-a050-8771e7db4551.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eye Clean | EYE WASH | HART Health | 41f53e2e-c2bc-4bf1-a541-3bcb2cf63002 | 2025-12-31 | Warnings | M |
| NUTRALOX | CALCIUM CARBONATE | HART Health | 3941b84e-3b4b-46eb-851b-979bac1ae997 | 2025-12-31 | Warnings | M |
| PVP Iodine | POVIDONE-IODINE | HART Health | 06b085dd-934d-40e9-aa0d-2dd9cdccd535 | 2025-12-31 | Warnings | M |
| WOUND WIPES | BENZALKONIUM CHLORIDE | HART Health | 4942195e-2941-4111-8ab7-2891c316bd27 | 2025-12-31 | Warnings | M |
| MG DermaGel 62 | ETHYL ALCOHOL | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | e6b2cc57-11a6-4808-a30f-8118a8de9fc6 | 2025-12-29 | Warnings | M |
| MG FoamSan | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | c5311836-674a-400b-a0d3-92f959d92682 | 2025-12-29 | Warnings | M |
| CETAFEN EXTRA | ACETAMINOPHEN | HART Health | 38db0b09-37f8-4fed-903e-81e89486b39b | 2025-12-24 | Warnings | M |
| CETAFEN | ACETAMINOPHEN | HART Health | c1162bab-377d-4e17-9417-ccd20d29148b | 2025-12-24 | Warnings | M |
| CETAFEN COUGH and COLD | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL , GUAIFENESIN, , | HART Health | 44da0d8c-4a12-4122-99da-781e2809e1a8 | 2025-12-24 | Warnings | M |
| Adult Low Dose Aspirin | ASPIRIN | Pharbest Pharmaceuticals, Inc. | 4522f745-b88d-4021-a5dc-0161f1967dc9 | 2025-12-24 | Warnings | M |
| MG DermaFoam | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 4a43a605-f333-4c76-a476-476a9cc2e13a | 2025-12-23 | Warnings | M |
| MG DermaGel 70 | ETHYL ALCOHOL | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 56ac723b-3ede-4c94-bf4a-0572a7b42b59 | 2025-12-23 | Warnings | M |
| MG DermaSan 72 | ISOPROPYL ALCOHOL | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | cccdefbc-09ef-417f-9b7a-1b254ae6e438 | 2025-12-23 | Warnings | M |
| MG FoamSan 70 | ETHYL ALCOHOL | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 11fc23dd-80e1-4df1-8c19-f759ecb34f1a | 2025-12-23 | Warnings | M |
| Hand Sanitizer Solution 101 | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 81fa10d3-6dbb-4a72-bfff-2dd795f94968 | 2025-12-23 | Warnings | M |
| MG DermaWash | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 0bb37363-418f-46c7-8c39-9ef9aa5023f7 | 2025-12-23 | Warnings | M |
| MG DermaGel 62 LV | ETHYL ALCOHOL | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | 437a508d-31ba-49b4-b821-4bf57b596e33 | 2025-12-23 | Warnings | M |
| Antibacterial Liquid Hand | BENZALKONIUM CHLORIDE | Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc. | ea0a5970-e95f-4090-bbe3-7df9e04393b5 | 2025-12-23 | Warnings | M |
| MG DermaClean | N/A | Morgan Gallacher Inc. | ed3d983e-0a6e-4de4-832a-0020f7711011 | 2025-12-23 | Warnings | M |
| MG DermaSan | N/A | Morgan Gallacher Inc. | d4c0de39-8570-4a05-a5e3-3752545ed95f | 2025-12-23 | Warnings | M |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 8b7cc0d5-029b-43f7-a050-8771e7db4551 | 4 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 8b7cc0d5-029b-43f7-a050-8771e7db4551 | 4 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 8b7cc0d5-029b-43f7-a050-8771e7db4551 | 4 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 8b7cc0d5-029b-43f7-a050-8771e7db4551 | 4 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 8b7cc0d5-029b-43f7-a050-8771e7db4551 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 17856-8237-2 | 17856823702 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8237-2) > 10 mL in 1 CUP, UNIT-DOSE | 2020-05-04 | 0000-00-00 | No | No | Current |